Kiniksa Pharmaceuticals
KNSAInsider trades and stock quote 2024-2026
All insider trades at Kiniksa Pharmaceuticals
Subscribe RSS| Date | Type | Insider | Position | Ø-Price | Volume |
|---|---|---|---|---|---|
| 3/9/2026 | Sell | Ragosa, Mark | CHIEF FINANCIAL OFFICER | $45.9 | $1,686,158 |
| 3/2/2026 | Sell | Paolini, John F. | CHIEF MEDICAL OFFICER | $45.0 | $1,792,940 |
| 2/12/2026 | Sell | Quart, Barry D. | Director | $45.0 | $121,050 |
| 2/10/2026 | Sell | Quart, Barry D. | Director | $45.0 | $4,950 |
| 2/9/2026 | Sell | Ragosa, Mark | CHIEF FINANCIAL OFFICER | $43.3 | $772,254 |
All information without guarantee! No recommendation/consultation!
© U.S. Securities and Exchange Commission (SEC)